Retractable Technologies Inc (RVP) stock
RVPNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 11/3082% below fair value
$0.57+0.01 (+0.91%)
Close on Nov 17, 2026Market cap $16.92MP/E –Yield –
Retractable Technologies r&d expenses
Research and development expenses are spending on new products and technology.
Retractable Technologies's R&D Expenses for the twelve months ending Jun 30, 2026 was $682.03K, down 0.3% year over year. For fiscal 2025 it was $675.57K, up 0.2% from the year before. Over ten years it grew 1.1% a year on average. The highest annual figure on record is $1.03M in fiscal 2009.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $675.57K | +0.2% |
| FY2024 | Dec 31, 2024 | $673.94K | +16.0% |
| FY2023 | Dec 31, 2023 | $581.17K | +10.5% |
| FY2022 | Dec 31, 2022 | $525.73K | -41.7% |
| FY2021 | Dec 31, 2021 | $901.38K | +56.9% |
| FY2020 | Dec 31, 2020 | $574.53K | +11.3% |
| FY2019 | Dec 31, 2019 | $516.10K | -16.9% |
| FY2018 | Dec 31, 2018 | $621.37K | -16.1% |
| FY2017 | Dec 31, 2017 | $740.57K | +29.5% |
| FY2016 | Dec 31, 2016 | $571.84K | -5.9% |
| FY2015 | Dec 31, 2015 | $607.53K | -1.5% |
| FY2014 | Dec 31, 2014 | $616.78K | -26.3% |
| FY2013 | Dec 31, 2013 | $837.07K | -4.0% |
| FY2012 | Dec 31, 2012 | $871.85K | +7.0% |
| FY2011 | Dec 31, 2011 | $815.02K | -8.0% |
| FY2010 | Dec 31, 2010 | $885.45K | -14.1% |
| FY2009 | Dec 31, 2009 | $1.03M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $187.29K | +17.0% |
| Q1 FY2026 | Mar 31, 2026 | $170.42K | -10.9% |
| Q4 FY2025 | Dec 31, 2025 | $124.86K | -20.9% |
| Q3 FY2025 | Sep 30, 2025 | $199.46K | +14.2% |
| Q2 FY2025 | Jun 30, 2025 | $160.05K | -19.6% |
| Q1 FY2025 | Mar 31, 2025 | $191.19K | +34.4% |
| Q4 FY2024 | Dec 31, 2024 | $157.89K | -2.4% |
| Q3 FY2024 | Sep 30, 2024 | $174.70K | +15.7% |
| Q2 FY2024 | Jun 30, 2024 | $199.09K | +43.5% |
| Q1 FY2024 | Mar 31, 2024 | $142.26K | +9.6% |
| Q4 FY2023 | Dec 31, 2023 | $161.70K | +37.0% |
| Q3 FY2023 | Sep 30, 2023 | $150.96K | +42.8% |
| Q2 FY2023 | Jun 30, 2023 | $138.76K | -32.8% |
| Q1 FY2023 | Mar 31, 2023 | $129.76K | +35.8% |
| Q4 FY2022 | Dec 31, 2022 | $118.05K | -23.3% |
| Q3 FY2022 | Sep 30, 2022 | $105.75K | -46.9% |
| Q2 FY2022 | Jun 30, 2022 | $206.39K | -48.3% |
| Q1 FY2022 | Mar 31, 2022 | $95.54K | -36.0% |
| Q4 FY2021 | Dec 31, 2021 | $153.86K | +21.9% |
| Q3 FY2021 | Sep 30, 2021 | $199.20K | +43.8% |
| Q2 FY2021 | Jun 30, 2021 | $399.04K | +188.7% |
| Q1 FY2021 | Mar 31, 2021 | $149.28K | +10.6% |
| Q2 FY2020 | Jun 30, 2020 | $126.26K | +9.3% |
| Q1 FY2020 | Mar 31, 2020 | $138.54K | +8.7% |
| Q4 FY2019 | Dec 31, 2019 | $138.21K | -26.9% |
| Q3 FY2019 | Sep 30, 2019 | $134.92K | -7.9% |
| Q2 FY2019 | Jun 30, 2019 | $115.51K | -18.4% |
| Q1 FY2019 | Mar 31, 2019 | $127.46K | -11.6% |
| Q4 FY2018 | Dec 31, 2018 | $189.19K | -31.2% |
| Q3 FY2018 | Sep 30, 2018 | $146.49K | -8.4% |
| Q2 FY2018 | Jun 30, 2018 | $141.47K | -10.1% |
| Q1 FY2018 | Mar 31, 2018 | $144.23K | -2.8% |
| Q4 FY2017 | Dec 31, 2017 | $274.80K | +50.9% |
| Q3 FY2017 | Sep 30, 2017 | $159.92K | +35.6% |
| Q2 FY2017 | Jun 30, 2017 | $157.40K | +7.2% |
| Q1 FY2017 | Mar 31, 2017 | $148.45K | – |
| Q4 FY2016 | Dec 31, 2016 | $182.13K | – |
| Q3 FY2016 | Sep 30, 2016 | $117.94K | – |
| Q2 FY2016 | Jun 30, 2016 | $146.85K | – |
See a number that looks wrong?